Prohibitins (PHB-1 and PHB-2) form a large macromolecular structure at the mitochondrial inner membrane. Prohibitin deficiency shortens the lifespan of wild type animals, but dramatically extends the lifespan of a variety of metabolically compromised animals such as insulin/IGF-1 receptor (
daf-2) mutants. This phenotype is accompanied by a differential induction of the mitochondrial Unfolded Protein Response (UPRmt), a stress protective mechanism that is attenuated in
daf-2 mutants. Through a genome wide RNAi screen we identified Heterochromatin Protein 1 (HP1) as a new regulator of the UPRmt. HP1 proteins (HPL-1 and HPL-2 in C. elegans) bind histone H3 methylated on lysine 9 to maintain chromatin in a repressed state during development. We observed induction of the UPRmt in HP1 single and double mutants, as well as decreased basal and maximal respiration compared to wild type animals, suggesting a mitochondrial dysfunction. This is supported by an increased sensitivity of HP1 mutants to the antibiotic doxycycline, which specifically blocks mitochondrial translation. Furthermore, HP1 protein levels increased in response to
phb-1 depletion, both, in otherwise wild type animals and in
daf-2 mutants. Interestingly,
hpl-1 mutants reduced the UPRmt triggered by
phb-1 depletion, but suppressed the attenuated UPRmt in PHB-depleted
daf-2 mutants. HPL-1 protein levels increase as animals age, while HPL-2 remains steady. Interestingly,
hpl-1 deletion extended lifespan independently of
phb-1. However, in
daf-2 mutants,
hpl-1 was required for the enhanced longevity conferred by PHB depletion. We are currently investigating which genes are targeted by HP1 proteins under conditions leading to opposing ageing phenotypes. Given the evolutionary conservation of ageing mechanisms and the proteins under study, research in short-lived model systems amenable to genetic dissection, such as C. elegans, is likely to be beneficial to human health.